Glaxo (GSK) -3.1% after saying it will take a whopping £2.2B ($3.5B) Q4 charge to settle...

|By:, SA News Editor

Glaxo (GSK) -3.1% after saying it will take a whopping £2.2B ($3.5B) Q4 charge to settle lawsuits and regulatory fines, primarily in connection to Avandia. Worryingly, it also says there's no guarantee the provisions announced will cover its full legal bill.